177lu-dotatate - Open Access .click

Results 171 to 180 of about 3,791 (213)

Some of the next articles are maybe not open access.

Evaluation of Peritoneal Fluid Extracted from Patients Administered 177Lu-DOTATATE

Health Physics
Abstract Patients experiencing ascites, the buildup of fluid in the peritoneal cavity, frequently undergo paracentesis to drain fluid from their peritoneal cavity via a peritoneal port. Some patients experiencing ascites may require nuclear medicine procedures to address other medical conditions.
Christopher, Helstern, Ling Hsiu, Chung, Kenneth, Lewis +2 more
openaire +2 more sources

68Ga-DOTATOC Pictorial Essay of Various Recurrent Meningiomas Rejected for Treatment With 177Lu-DOTATATE: Is There a Place for Another Theranostic Examination?

Clinical Nuclear Medicine
We report the cases of 4 patients treated for recurrent meningiomas of various grades. Pretreatment 68Ga-DOTATOC PET/CT was performed prior to screening for vectorized internal radiotherapy with 177Lu-DOTATATE or prior external radiotherapy to aid ...
Aurélie Moreau, A. Maureille, David Kryza +2 more
semanticscholar +1 more source

Elevated Baseline Mean Corpuscular Volume Predicts the Development of Severe Hematologic Toxicity After 177Lu-DOTATATE Therapy

Journal of Nuclear Medicine
Visual Abstract 177Lu-DOTATATE is an effective second-line treatment for metastatic or nonresectable neuroendocrine tumors. This treatment can result in hematologic severe adverse reactions (SARs).
Andrew F. Voter +5 more
semanticscholar +1 more source

Neuroendocrine tumor therapy with 177Lu-DOTATATE: the dosimetric approach